A Study to Evaluate Once Daily Low Dose and High Dose Solabegron or Placebo Given for 12 Weeks to Treat Women With Symptoms of Overactive Bladder: Sudden Urge to Urinate, Frequent Urination Associated With Wetting Episodes (VEL-2001)

PHASE2CompletedINTERVENTIONAL
Enrollment

1,413

Participants

Timeline

Start Date

July 9, 2018

Primary Completion Date

April 29, 2019

Study Completion Date

May 2, 2019

Conditions
Overactive Bladder
Interventions
DRUG

Solabegron modified release tablets, low dose

Solabegron modified release tablets low dose or high dose or matching placebo once daily for 12 weeks.

DRUG

Solabegron modified release tablets, high dose

Solabegron modified release tablets low dose or high dose or matching placebo once daily for 12 weeks.

DRUG

Matching Placebo

Solabegron modified release tablets low dose or high dose or matching placebo once daily for 12 weeks.

Trial Locations (77)

19446

Velicept Investigative Site - Lansdale, Lansdale

27612

Velicept Investigative Site - Raleigh, Raleigh

29301

Velicept Investigative Site - Spartanburg, Spartanburg

29406

Velicept Investigative Site - Charleston, Charleston

29407

Velicept Investigative Site - Charleston, Charleston

29707

Velicept Investigative Site - Fort Mill, Fort Mill

30078

Velicept Investigative Site - Snellville, Snellville

30328

Velicept Investigative Site - Atlanta, Atlanta

32132

Velicept Investigative Site - Edgewater, Edgewater

33012

Velicept Investigative Site - Hialeah, Hialeah

33015

Velicept Investigative Site - Miami, Miami

33024

Velicept Investigative Site - Hollywood, Hollywood

33060

Velicept Investigative Site - Pompano Beach, Pompano Beach

33144

Velicept Investigative Site - Miami, Miami

33155

Velicept Investigative Site - Miami, Miami

33166

Velicept Investigative Site - Doral(2), Doral

Velicept Investigative Site - Doral, Doral

Velicept Investigative Site - Miami Springs, Miami Springs

33180

Velicept Investigative Site - Aventura, Aventura

33319

Velicept Investigative Site - Lauderdale Lakes, Lauderdale Lakes

33409

Velicept Investigative Site - West Palm Beach, West Palm Beach

33615

Velicept Investigative Site - Tampa, Tampa

34653

Velicept Investigative Site - New Port Richey, New Port Richey

34684

Velicept Investigative Site - Palm Harbor, Palm Harbor

35209

Velicept Investigative Site - Birmingham, Birmingham

35215

Velicept Investigative Site - Birmingham, Birmingham

35976

Velicept Investigative Site - Guntersville, Guntersville

36571

Velicept Investigative Site - Saraland, Saraland

37421

Velicept Investigative Site - Chattanooga, Chattanooga

37938

Velicept Investigative Site - Knoxville, Knoxville

38301

Velicept Investigative Site - Jackson, Jackson

38654

Velicept Investigative Site - Olive Branch, Olive Branch

39531

Velicept Investigative Site - Biloxi, Biloxi

45439

Velicept Investigative Site - Dayton, Dayton

48605

Velicept Investigative Site - Saginaw, Saginaw

58103

Velicept Investigative Site - Fargo, Fargo

68128

Velicept Investigative Site - La Vista, La Vista

70006

Velicept Investigative Site - Metairie, Metairie

70526

Velicept Investigative Site - Crowley, Crowley

73064

Velicept Investigative Site - Mustang, Mustang

73120

Velicept Investigative Site - Oklahoma City, Oklahoma City

75010

Velicept Investigative Site - Carrollton, Carrollton

75024

Velicept Investigative Site - Plano(1), Plano

Velicept Investigative Site - Plano(2), Plano

75224

Velicept Investigative Site - Dallas, Dallas

76135

Velicept Investigative Site - Fort Worth, Fort Worth

76904

Velicept Investigative Site - San Angelo, San Angelo

77030

Velicept Investigative Site - Houston, Houston

77082

Velicept Investigative Site - Houston, Houston

77478

Velicept Investigative Site - Sugar Land, Sugar Land

77802

Velicept Investigative Site - Bryan, Bryan

78209

Velicept Investigative Site - San Antonio, San Antonio

78229

Velicept Investigative Site - San Antonio, San Antonio

78626

Velicept Investigative Site - Georgetown, Georgetown

78704

Velicept Investigative Site - Austin, Austin

78705

Velicept Investigative Site - Austin, Austin

80012

Velicept Investigative Site - Aurora, Aurora

80113

Velicept Investigative Site - Englewood, Englewood

85741

Velicept Investigative Site - Tucson, Tucson

85745

Velicept Investigative Site - Tucson, Tucson

89109

Velicept Investigative Site - Las Vegas, Las Vegas

89117

Velicept Investigative Site - Las Vegas, Las Vegas

89128

Velicept Investigative Site - Las Vegas, Las Vegas

91606

Velicept Investigative Site - North Hollywood, North Hollywood

91786

Velicept Investigative Site - Upland, Upland

91978

Velicept Investigative Site - Spring Valley, Spring Valley

92108

Velicept Investigative Site - San Diego, San Diego

92111

Velicept Investigative Site - San Diego, San Diego

95648

Velicept Investigative Site - Lincoln, Lincoln

95864

Velicept Investigative Site - Sacramento, Sacramento

97030

Velicept Investigative Site - Gresham, Gresham

06320

Velicept Investigative Site - New London, New London

02135

Velicept Investigative Site - Brighton, Brighton

02747

Velicept Investigative Site - North Dartmouth, North Dartmouth

08837

Velicept Investigative Site - Edison, Edison

02914

Velicept Investigative Site - East Providence, East Providence

02865

Velicept Investigative Site - Lincoln, Lincoln

All Listed Sponsors
lead

Velicept Therapeutics, Inc.

INDUSTRY

NCT03594058 - A Study to Evaluate Once Daily Low Dose and High Dose Solabegron or Placebo Given for 12 Weeks to Treat Women With Symptoms of Overactive Bladder: Sudden Urge to Urinate, Frequent Urination Associated With Wetting Episodes (VEL-2001) | Biotech Hunter | Biotech Hunter